<DOC>
	<DOC>NCT00182247</DOC>
	<brief_summary>To simplify and improve the diagnostic approach to patients with clinically suspected recurrent DVT by determining whether the results of the combination of IPG and d-dimer testing, using a whole blood agglutination assay, can be used in the management of such patients.</brief_summary>
	<brief_title>D-Dimer and IPG for Recurrent Thrombosis (DIRECT)</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Fibrin fragment D</mesh_term>
	<criteria>suspected deep vein thrombosis history of previous DVT or PE comorbid condition limiting survival to less than 6 months contraindication to contrast medium (allergy, renal dysfunction, creatinine &gt; 150mcmol/L) receiving longterm warfarin or heparin therapy received fulldose heparin therapy for more than 48 hours pregnancy symptomatic for pulmonary embolism absence of symptoms within 5 days of presentation geographic inaccessibility which precludes followup</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>deep vein thrombosis</keyword>
	<keyword>DVT</keyword>
	<keyword>pulmonary embolism</keyword>
	<keyword>PE</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>VTE</keyword>
	<keyword>d-dimer</keyword>
	<keyword>IPG</keyword>
</DOC>